FDA Office Of Regulatory Affairs Make-Over Blends Domestic, International Work
This article was originally published in The Gray Sheet
Executive Summary
The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.
You may also be interested in...
People Briefs: Encision, Solta, Chembio, Accuray, Devon and FDA
Encision CEO Fred Perner dead at 59. Solta Medical CEO resigns. Chembio president and CEO announces he will retire in May. FDA gains permanent regulatory affairs chief. More people news.
People In Brief
Former Lutonix chief Dennis Wahr takes helm at Innovative Pulmonary Solutions. FDA gets two new associate commissioners. More people news.
FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts
FDA's Office of Regulatory Affairs still plans to reorganize, despite its recent decision to cancel the planned closure of seven field labs